Cellectis SA(CLLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CLLS Cellectis SA

Market Closed 06-12 16:00:00 EDT

3.09

+0.00

0.00%

盘后3.09

+0.000.00%

16:04 EDT

High3.24	Low3.05	Vol36.73K
Open3.24	D1 Closing3.09	Amplitude6.15%
Mkt Cap312.09M	Tradable Cap206.75M	Total Shares101.00M
T/O115.30K	T/O Rate0.05%	Tradable Shares66.91M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CLLS","market":"US","secType":"STK","nameCN":"Cellectis SA","latestPrice":3.09,"timestamp":1781294400000,"preClose":3.09,"halted":0,"volume":36725,"hourTrading":{"tag":"盘后","latestPrice":3.09,"preClose":3.09,"latestTime":"16:04 EDT","volume":804,"amount":2484.36,"timestamp":1781294688233,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0,"floatShares":66909900,"shares":101000000,"eps":-0.670046,"marketStatus":"Market Closed","change":0,"latestTime":"06-12 16:00:00 EDT","open":3.24,"high":3.24,"low":3.05,"amount":115297,"amplitude":0.061489,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.670046,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1781510400000},"marketStatusCode":7,"adr":1,"adrRate":1,"listingDate":1427256000000,"exchange":"NASDAQ","adjPreClose":3.09,"preHourTrading":{"tag":"盘前","latestPrice":3.2446,"preClose":3.09,"latestTime":"07:41 EDT","volume":1689,"amount":5642.4615545999995,"timestamp":1781264502535,"change":0.1546,"changeRate":0.050032,"amplitude":0.03411},"postHourTrading":{"tag":"盘后","latestPrice":3.09,"preClose":3.09,"latestTime":"16:04 EDT","volume":804,"amount":2484.36,"timestamp":1781294688233,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.562877,"impliedVol":0.4603,"impliedVolPercentile":0.1036},"requestUrl":"/m/hq/s/CLLS","defaultTab":"news","newsList":[{"id":"2642233239","title":"Cellectis Says Phase 1 Lasme-cel Study Shows 100% Response Rate in B-Cell Leukemia Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2642233239","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642233239?lang=en_us&edition=fundamental","pubTime":"2026-06-11 23:57","pubTimestamp":1781193431,"startTime":"0","endTime":"0","summary":"Cellectis (CLLS) said Thursday that data from a phase 1 trial of lasme-cel in relapsed/refractory B-cell acute lymphoblastic leukemia, or r/r B-ALL, reflected strong response and remission rates.The s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","CLLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642401957","title":"Cellectis Presents Final Phase 1 Results of Lasme-cel and  Preliminary Results on Eti-cel at EHA 2026 Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2642401957","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642401957?lang=en_us&edition=fundamental","pubTime":"2026-06-11 14:40","pubTimestamp":1781160000,"startTime":"0","endTime":"0","summary":"NEW YORK, June  11, 2026  (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to de","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/11/3310207/0/en/Cellectis-Presents-Final-Phase-1-Results-of-Lasme-cel-and-Preliminary-Results-on-Eti-cel-at-EHA-2026-Congress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAR","BK4230","LU2065731478.USD","BK4006","IE00B19Z4B17.USD","ORR","BK4231","BK4187","IE0031619046.USD","BK4161","LU0963586101.USD","ADC","BK4022","BK4080","HSCT","CR","IE00B7SZL793.SGD","CLLS","CRS","IE00B66KJ199.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642249709","title":"Cellectis granted RMAT designation for lasmecabtagene timgedleucel from FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2642249709","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642249709?lang=en_us&edition=fundamental","pubTime":"2026-06-10 04:40","pubTimestamp":1781037612,"startTime":"0","endTime":"0","summary":"Cellectis (CLLS) announced that the FDA granted Regenerative Medicine Advanced Therapy, or RMAT, designation to lasmecabtagene timgedleucel, its CD...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cellectis-granted-rmat-designation-for-lasmecabtagene-timgedleucel-from-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cellectis-granted-rmat-designation-for-lasmecabtagene-timgedleucel-from-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4023","BK4116","BK4139","BK4127","LABU","BK4585","CLLS","BK4588","CD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642977644","title":"Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL","url":"https://stock-news.laohu8.com/highlight/detail?id=2642977644","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642977644?lang=en_us&edition=fundamental","pubTime":"2026-06-10 04:30","pubTimestamp":1781037000,"startTime":"0","endTime":"0","summary":"NEW YORK, June  09, 2026  (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to de","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/09/3309345/0/en/Cellectis-Receives-FDA-RMAT-Designation-for-lasme-cel-the-First-Allogeneic-CAR-T-Therapy-in-a-Pivotal-Trial-for-Patients-with-r-r-B-ALL.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","TX","CAR","BK4585","BK4139","LU1571399168.USD","LU2355687059.USD","LU0985320562.USD","BK4230","BK4006","LU0640798160.USD","BK4022","LU1699723380.USD","BK4107","CLLS","ALL","BK4533","LU1115378108.SGD","IE00B3M56506.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642496572","title":"European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2642496572","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642496572?lang=en_us&edition=fundamental","pubTime":"2026-06-09 23:11","pubTimestamp":1781017898,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending higher late Tuesday morning, rising 0.80% to 1,882.97 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis  and semiconductor company Sequans Communications , which rose 3.8% and 3.7% respectively. They were followed by healthcare tech company Royal Philips  and biopharmaceutical company Grifols , which were up 2.9% and 2.5% respectively.The decliners from continental Europe were led by telecommunications company Ericsson  and petroleum refiner Equinor , which dropped 5% and 2.6% respectively. They were followed by telecommunications company Nokia  and SAP , which lost 1.5% and 1% respectively.The gainers from the UK were led by communications company WPP  and biopharmaceutical company Amarin , which advanced 7.9% and 5.6% respectively. They were followed by pharmaceutical company Silence Therapeutics  and biopharmaceutical company Akari Th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EPV","DRIP","BK4591","IXC","LU0006061336.USD","AFG","HSBH","GRFS","LU0211326839.USD","CLLS","BK4117","LU0162691827.USD","IEUR","XES","BP","BPH","NOK","BK4141","HSBC","DRLL","ERIC","WPP.AU","DBE","WPP","SLN","BDRX","DBC","BK4139","IEO","SQNS","DIG","SHEH","PHG","WTIU","SAP","LU0310800965.SGD","PXJ","USE","VDE","AKTX","FTXN","GUSH","SHEL","BK4613","ERX","LNOK","EQNR","AMRN","PXE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641438597","title":"European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2641438597","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641438597?lang=en_us&edition=fundamental","pubTime":"2026-06-08 23:10","pubTimestamp":1780931424,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts kicked off the week higher late Monday morning, lifting 0.82% to 1,874.41 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications  and biotech firm Evaxion , which rose 7% and 4.5% respectively. They were followed by accommodations booking company trivago  and telecommunications company Nokia , which increased 4.4% and 1.7% respectively.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk  and biopharmaceutical company Cellectis , which fell 2.9% and 2.3% respectively. They were followed by pharmaceutical company Sanofi  and biopharmaceutical company Grifols , which were down 2% each.The gainers from the UK were led by biopharmaceutical companies Biodexa Pharmaceuticals  and NuCana , which advanced 4.5% and 3.3% respectively. They were followed by oil and gas company BP  and biopharmaceutical company Amarin , which ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EVAX","AMRN","BK4007","BK4077","BK4599","GSKH","GSK.UK","BK4141","BK4201","CLLS","NOK","BK4532","SQNS","BK4505","BK4547","BK4208","GRFS","LU1093756168.USD","BP","IE00BMPRXR70.SGD","LU0320765646.SGD","LU1093756325.SGD","NVOH","IE00BFXG1179.USD","TRVG","BK4139","AUTL","LU0300736062.USD","SNY","GSK","LU0300736492.USD","BDRX","MREO","BK4020","IE00BKVL7J92.USD","LU1829250122.USD","IE00BMPRXN33.USD","LNOK","NVOX","LU0072461881.USD","NCNA","LU0162691827.USD","BPH","LU0006061336.USD","LU0154236417.USD","BK4585","IE00BZ1G4Q59.USD","NGG","LU1162221912.USD","BK4588","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641368149","title":"European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Rise for Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2641368149","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641368149?lang=en_us&edition=fundamental","pubTime":"2026-06-05 23:06","pubTimestamp":1780672000,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking lower late Friday morning, falling 0.85% to 1,882.19 on the S&P Europe Select ADR Index, which is up 0.9% for the week ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SQNS","BK7507","SLN","IE00BJT1NW94.SGD","LU0300736492.USD","NOK","IE00BFMHRM44.USD","IE00BMPRXR70.SGD","DEO","LU1983260115.SGD","AUTL","BK4117","IEUR","LNOK","IE00BFTCPJ56.SGD","AKTX","TRIB","BK4169","BK4554","BK4075","CRTO","LU0124676726.USD","DBVT","ERIC","BTI.AU","BK4009","ULVR.UK","LU0889565916.HKD","BK4141","CLLS","PSO","BK4588","LU0320765992.SGD","ARGX","DGE.UK","BK4082","IE0002141913.USD","LU0109394709.USD","BHP","EPV","BHP.AU","AFG","UL","BK4559","BK4591","UN","BTI","IE00B2B36J28.USD","BK4139","LU0689626769.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640884841","title":"European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2640884841","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640884841?lang=en_us&edition=fundamental","pubTime":"2026-06-03 23:10","pubTimestamp":1780499458,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were declining late Wednesday morning, falling 0.58% to 1,880.17 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications company Nokia  and petroleum refiner Equinor , which rose 2.1% and 1.3%, respectively. They were followed by oil and gas company Eni  and biopharmaceutical company argenx , which were up 1% and 0.5%, respectively.The decliners from continental Europe were led by internet ad firm Criteo  and biopharmaceutical company Cellectis , which fell 7% and 4.7%, respectively. They were followed by biotech firm Evaxion  and software company SAP , which were down 4.6% and 4.5%, respectively.The gainers from the UK were led by Mereo BioPharma Group , which advanced 5.6%. It was followed by pharmaceutical company Silence Therapeutics  and medical device maker Smith & Nephew , which increased 4.8% and 2%, respectively.The decliners from the UK and Ireland were led by com","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SLN","NOK","IE00BFMHRM44.USD","BK4134","IE00BMPRXN33.USD","IE00BMPRXR70.SGD","BK4521","LU1983260115.SGD","AUTL","LU2324357040.USD","BK4207","IEUR","EQNR","LNOK","IE00BFTCPJ56.SGD","NCNA","BK4020","CRTO","BK4505","BK4009","WPP","WPP.AU","LU0889565916.HKD","IE0034235188.USD","CLLS","DAVA.AU","BK4107","BK4585","BK4588","SAP","BCS","LU0320765992.SGD","ARGX","LU0084288595.USD","E","IE0002141913.USD","LU0109394709.USD","DAVA","BK4201","EPV","IE00BJJMRZ35.SGD","AFG","BK4547","SNN","IE0009355771.USD","MREO","IE00B4R5TH58.HKD","IE00B2B36J28.USD","BK4139","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638692834","title":"European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2638692834","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638692834?lang=en_us&edition=fundamental","pubTime":"2026-05-28 23:14","pubTimestamp":1779981250,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending slightly lower late Thursday morning, declining 0.1% to 1,873.2 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by internet advertising firm Criteo  and medical device maker EDAP TMS , which rose 3.3% and 3.2% respectively. They were followed by biopharmaceutical company Cellectis  and software firm SAP , which were up 2.8% and 1.2% respectively.The decliners from continental Europe were led by telecommunications company Nokia  and brewing company Anheuser-Busch InBev , which fell 2.5% and 1.4% respectively. They were followed by biopharmaceutical company Grifols  and biotech firm BioNTech , which were down 1.1% and 0.3% respectively.The gainers from the UK were led by biopharmaceutical company Akari Therapeutics  and biotech firm Autolus Therapeutics , which advanced 43.9% and 1.5% respectively. They were followed by communications company WPP  and biopharmaceutical compan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EDAP","AFG","CLLS","LU0211326839.USD","IEUR","BDRX","SAP","AMRN","EPV","AKTX","BK4139","BK4107","PUK","LU0052756011.USD","BK4551","CRTO","BK4020","BK4023","BK4528","BUD","LU0310800965.SGD","BK4548","BK4588","LU0128525689.USD","LU0976567544.SGD","BK4613","BK4585","BK7119","LU2236285917.USD","SLN","BK4158","BK4535","LU1267930227.SGD","HSBC","BK4009","BNTX","BK4207","BUD.AU","WPP.AU","FOCL","GRFS","HSBH","NOK","WPP","LNOK","LU0211326755.USD","AUTL","IE00BMPRXN33.USD","BK4568","LU0496365809.HKD","IE00BFMHRM44.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638699951","title":"Cellectis Initiated at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2638699951","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638699951?lang=en_us&edition=fundamental","pubTime":"2026-05-28 21:46","pubTimestamp":1779975960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CLLS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 28, 2026 09:46 ET (13:46 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637736568","title":"Press Release: Cellectis' Annual Shareholders General Meeting to be Held on June 25, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2637736568","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637736568?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:30","pubTimestamp":1779309000,"startTime":"0","endTime":"0","summary":"NEW YORK, May 20, 2026  -- Cellectis  , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that it will hold its annual general meeting on June 25, 2026 at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France.Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. The company utilizes an allogeneic approach for CAR T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients, and a platform to develop gene therapies in other therapeutic indications. With its in-house manufacturing capabilities, Cellectis is one of the few end-to-end gene editing companies that controls the cell and gene therapy value chain from start to finish.Cellectis' headquarters are in Paris, France, with locations in New York an","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636985076","title":"European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2636985076","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636985076?lang=en_us&edition=fundamental","pubTime":"2026-05-19 23:27","pubTimestamp":1779204425,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending lower late Tuesday morning, declining 0.3% to 1,824.16 on the S&P Europe Select ADR Index.From continental Europe, the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2324357040.USD","EPV","BK4023","BK7507","AFG","BK4168","BK4547","LU1983260115.SGD","BK4588","EDAP","IE00BJJMRZ35.SGD","LU0109394709.USD","CLLS","SNN","BK4117","BK4009","IEUR","BK7511","LU0300736492.USD","BK4201","NCNA","IE0034235188.USD","NOK","AUTL","BHP","BK7095","LU0889565916.HKD","IE00BFTCPJ56.SGD","IE0009355771.USD","SLN","BDRX","BHP.AU","ARGX","BK4107","BK4139","SQNS","SAP","BK4020","IE00BJT1NW94.SGD","BK4505","IE0002141913.USD","BK4007","AKTX","IE00BFMHRM44.USD","IE00BMPRXR70.SGD","CRTO","IE00B2B36J28.USD","BK4528","LNOK","EQNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635467777","title":"European Equities Traded in the US as American Depositary Receipts Tracking Higher in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2635467777","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635467777?lang=en_us&edition=fundamental","pubTime":"2026-05-14 23:04","pubTimestamp":1778771099,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were moving higher late Thursday morning, rising 0.43% to 1,852.92 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications  and 3D printer company Materialise , which climbed 11.4% and 10.4% respectively. They were followed by lender ING Group  and biopharmaceutical company Cellectis , which increased 2.3% and 2.1% respectively.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk  and internet browser company Opera , which fell 1.7% and 1.6% respectively. They were followed by oil and gas company Eni  and lender Banco Santander , which were off 1.3% and 0.5% respectively.The gainers from the UK were led by biopharmaceutical companies NuCana  and Akari Therapeutics , which advanced 9.6% and 3.2% respectively. They were followed by communications company WPP  and lender Barclays , which were up 2.8% and 2.4% respectiv","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4117","BK4568","BK4588","LU0320765992.SGD","LU2237443465.HKD","LU2456880835.USD","BK4139","LU2236285917.USD","BK7095","NVO","BK7141","LU1829250122.USD","NVOH","BK4521","BCS","BK7505","LU0154236417.USD","OPRA","BK4546","AUTL","BK7511","BK4599","E","LU0289739699.SGD","BK4207","LU2237443549.SGD","BHP","IE00B3T34201.USD","LU2417539215.USD","LU1093756168.USD","SAN","SQNS","BK4007","AZN","BK4107","AZNH","LU0889565916.HKD","MTLS","BK4201","LU0300736062.USD","LU0300736492.USD","IE00BKVL7J92.USD","NVOX","WPP","BK4585","LU0058720904.USD","BK7507","BK4168","BK4141","LU2237443622.USD","AMRN","BK4023","LU1093756325.SGD","AKTX","LU2237443895.HKD","LU2237443978.SGD","NCNA","BK4532","IE00BZ1G4Q59.USD","ING","BK4009","LU2237443382.USD","BK7104","CLLS","BK7142","LU2462157665.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634436482","title":"European Equities Traded in the US as American Depositary Receipts Decline Sharply in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2634436482","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634436482?lang=en_us&edition=fundamental","pubTime":"2026-05-12 23:14","pubTimestamp":1778598868,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were down significantly late Tuesday morning, dropping 1.05% to 1,814.06 on the S&P Europe Select ADR Index.From continental Europe, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EPV","LU2543165471.USD","GSKH","MTLS","BK4142","BK4023","CRTO","BK4132","DBVT","BK4107","AFG","BK4077","GSK.UK","CUK","BK4521","LNOK","BK4117","LU0006061336.USD","BK4020","LYG","BK4141","IE00BMPRXR70.SGD","NOK","BK4585","SLN","TRVG","BK4546","BK4139","SQNS","BK4075","AKTX","BK7062","BTI","IE00BFMHRM44.USD","BK4588","BTI.AU","IE00BMPRXN33.USD","MREO","BK4007","LU0072461881.USD","LU1829250122.USD","LU0162691827.USD","CLLS","VOD","BK4207","GSK","IEUR","BK4532","OPRA","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634217382","title":"Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2634217382","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634217382?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:30","pubTimestamp":1778592600,"startTime":"0","endTime":"0","summary":"NEW YORK, May  12, 2026  (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to dev","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3293001/0/en/Cellectis-to-Present-Clinical-Data-on-Lasme-cel-and-Eti-cel-at-EHA-2026-Annual-Congress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0640798160.USD","TX","BK4006","BK4139","CLLS","LU1115378108.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634256287","title":"Cellectis SA reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2634256287","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634256287?lang=en_us&edition=fundamental","pubTime":"2026-05-12 07:21","pubTimestamp":1778541707,"startTime":"0","endTime":"0","summary":"Cellectis SA reports results for the quarter ended March 31 - Earnings SummaryCellectis SA CLLS.OQ reported a quarterly adjusted loss of 18 cents per share for the quarter ended March 31, identical to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL8N41O2UD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634230698","title":"Cellectis Q1 Adj. EPS $(0.16) Beats $(0.27) Estimate, Sales $7.548M Miss $12.267M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2634230698","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634230698?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:32","pubTimestamp":1778531554,"startTime":"0","endTime":"0","summary":"Cellectis (NASDAQ:CLLS) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.27) by 40.74 percent. This is a 5.88 percent increase over losses of $(0.17) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52470067/cellectis-q1-adj-eps-0-16-beats-0-27-estimate-sales-7-548m-miss-12-267m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cellectis Q1 Adj. EPS $(0.16) Beats $(0.27) Estimate, Sales $7.548M Miss $12.267M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634230959","title":"Cellectis Reports Financial Results for the First Quarter 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2634230959","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634230959?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:30","pubTimestamp":1778531400,"startTime":"0","endTime":"0","summary":"Pivotal Phase 2 with lasme-cel in r/r B-ALL (BALLI-01 trial) Pivotal Phase 2 first interim analysis expected in Q4 2026BLA submission anticipated in 2028 Phase 1 with eti-cel in r/r NHL (NATHALI-01 tr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/11/3292381/0/en/Cellectis-Reports-Financial-Results-for-the-First-Quarter-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZL793.SGD","BK4161","LU0963586101.USD","BK4187","IE00B66KJ199.SGD","BK4006","IE0031619046.USD","LU2065731478.USD","BK4139","ORR","CRS","CLLS","IE00B19Z4B17.USD","CR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634753238","title":"European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2634753238","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634753238?lang=en_us&edition=fundamental","pubTime":"2026-05-11 23:05","pubTimestamp":1778511940,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts opened the week on a flat note Monday morning, edging 0.08% higher to 1,835.34 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications  and biopharmaceutical company Cellectis , which advanced 8.1% and 6.3% respectively. They were followed by biopharmaceutical company DBV Technologies  and telecommunications company Ericsson , which increased 4.9% and 3.2% respectively.The decliners from continental Europe were led by consumer goods company Unilever  and biopharmaceutical company Grifols , which fell 1.9% and 1.3% respectively. They were followed by internet browser company Opera  and accommodations booking site trivago , which were down 1% each.The gainers from the UK were led by cruise line operator Carnival  and pharmaceutical company Silence Therapeutics , which rose 6.6% and 4.7% respectively. They were followed by biotech firm Autolus Therape","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DBVT","SLN","BK4117","BK4585","BK4591","BDRX","LU0124676726.USD","LU0689626769.HKD","BK4020","BK4134","CLLS","DAVA.AU","UL","BK4023","CUK","BK4515","GRFS","BK4588","IEUR","TRVG","BK4183","BK4142","BK4139","AKTX","EPV","UN","BK4505","AUTL","ERIC","BK4107","OPRA","BK4554","ULVR.UK","AMRN","BK4592","BK4077","MREO","BK4141","BK4007","LU0084288595.USD","LU0648005311.SGD","DAVA","SQNS","AFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634020034","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2634020034","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634020034?lang=en_us&edition=fundamental","pubTime":"2026-05-11 18:00","pubTimestamp":1778493600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·ATL Braves C                                   1Q      (.78)   8:00 AM","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCGO","ABCL","ARVN","ALLT","CLSK","ACRS","AMBQ","BIOA","BLNK","CGBD","AGNT","CEG","BALY","CHRS","BCAX","BGS","BATRA","B","ACET","ACH","ACXP","ATRO","CDRE","CLLS","APC","ACM","ALGS","ASRT","ARMK","ASTS","AIP","ACHV","APEI","AEYE","CBLL","AMTM","CERT","CVRX","BODI","CEVA","ANDG","BRCB","BTAI","CINT","COOK","ABOS","BATRK","BCSF","BETA","CRCL"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cellectis.com","stockEarnings":[{"period":"1week","weight":0.0098},{"period":"1month","weight":-0.2236},{"period":"3month","weight":-0.0965},{"period":"6month","weight":-0.3397},{"period":"1year","weight":1.2608},{"period":"ytd","weight":-0.3616}],"compareEarnings":[{"period":"1week","weight":0.0057},{"period":"1month","weight":-0.0008},{"period":"3month","weight":0.12},{"period":"6month","weight":0.088},{"period":"1year","weight":0.2286},{"period":"ytd","weight":0.0877}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates. The company is developing ALLO-715 and ALLO-605 for the treatment of multiple myeloma; ALLO-501 to treat large B-cell lymphoma; ALLO-316, an allogeneic engineered CAR T-cell product targeting CD70; ALLO-819 to treat acute myeloid leukemia; ALLO-213 for the treatment of small cell lung cancer; and ALLO-182 to treat gastric and pancreatic cancer. It also develops UCART22 for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia; UCART123 to treat acute myeloid leukemia; UCART 20x22 for relapsed or refractory B-Cell non-hodgkin's lymphoma; and cema-cel to treat relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma. The company has strategic alliances with Allogene Therapeutics, Inc. and Les Laboratoires Servier; research collaboration and exclusive license agreement with Iovance Biotherapeutics, Inc.; and joint research and collaboration, and investment agreement with AstraZeneca Holdings B.V., as well as with AstraZeneca Ireland Limited. Cellectis S.A. was founded in 1999 and is headquartered in Paris, France.","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.025762},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.069977},{"month":3,"riseRate":0.545455,"avgChangeRate":-0.047671},{"month":4,"riseRate":0.416667,"avgChangeRate":0.04499},{"month":5,"riseRate":0.583333,"avgChangeRate":0.041237},{"month":6,"riseRate":0.25,"avgChangeRate":-0.079623},{"month":7,"riseRate":0.363636,"avgChangeRate":0.040955},{"month":8,"riseRate":0.727273,"avgChangeRate":0.056431},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.108663},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.048106},{"month":11,"riseRate":0.545455,"avgChangeRate":0.268959},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.008306}],"exchange":"NASDAQ","name":"Cellectis SA","nameEN":"Cellectis SA","securityTypeName":"DR","adrRate":"1:1"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cellectis SA(CLLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Cellectis SA(CLLS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Cellectis SA,CLLS,Cellectis SA股票,Cellectis SA股票老虎,Cellectis SA股票老虎国际,Cellectis SA行情,Cellectis SA股票行情,Cellectis SA股价,Cellectis SA股市,Cellectis SA股票价格,Cellectis SA股票交易,Cellectis SA股票购买,Cellectis SA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cellectis SA(CLLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Cellectis SA(CLLS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction